Cargando…

Improvement of Tardive Dyskinesias with Olanzapine

Tardive dyskinesia (TD) is characterized by abnormal and involuntary movements that generally occur after prolonged exposure to neuroleptic medications. In this article, we present the case of a 29-year-old man with schizophrenia who developed TD following treatment with haloperidol. Despite various...

Descripción completa

Detalles Bibliográficos
Autores principales: Echater, S., Oneib, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615574/
https://www.ncbi.nlm.nih.gov/pubmed/37908858
http://dx.doi.org/10.1155/2023/6688623
_version_ 1785129251293364224
author Echater, S.
Oneib, B.
author_facet Echater, S.
Oneib, B.
author_sort Echater, S.
collection PubMed
description Tardive dyskinesia (TD) is characterized by abnormal and involuntary movements that generally occur after prolonged exposure to neuroleptic medications. In this article, we present the case of a 29-year-old man with schizophrenia who developed TD following treatment with haloperidol. Despite various attempts with benzodiazepines, amantadine, and anticholinergics, the dyskinesias persisted. However, after 2 years of treatment with olanzapine alone, a progressive improvement occurred, leading to the complete disappearance of the dyskinesias. We also provide a brief review of reported cases of antipsychotic-induced TD that has improved with olanzapine.
format Online
Article
Text
id pubmed-10615574
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-106155742023-10-31 Improvement of Tardive Dyskinesias with Olanzapine Echater, S. Oneib, B. Case Rep Psychiatry Case Report Tardive dyskinesia (TD) is characterized by abnormal and involuntary movements that generally occur after prolonged exposure to neuroleptic medications. In this article, we present the case of a 29-year-old man with schizophrenia who developed TD following treatment with haloperidol. Despite various attempts with benzodiazepines, amantadine, and anticholinergics, the dyskinesias persisted. However, after 2 years of treatment with olanzapine alone, a progressive improvement occurred, leading to the complete disappearance of the dyskinesias. We also provide a brief review of reported cases of antipsychotic-induced TD that has improved with olanzapine. Hindawi 2023-10-23 /pmc/articles/PMC10615574/ /pubmed/37908858 http://dx.doi.org/10.1155/2023/6688623 Text en Copyright © 2023 S. Echater and B. Oneib. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Echater, S.
Oneib, B.
Improvement of Tardive Dyskinesias with Olanzapine
title Improvement of Tardive Dyskinesias with Olanzapine
title_full Improvement of Tardive Dyskinesias with Olanzapine
title_fullStr Improvement of Tardive Dyskinesias with Olanzapine
title_full_unstemmed Improvement of Tardive Dyskinesias with Olanzapine
title_short Improvement of Tardive Dyskinesias with Olanzapine
title_sort improvement of tardive dyskinesias with olanzapine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615574/
https://www.ncbi.nlm.nih.gov/pubmed/37908858
http://dx.doi.org/10.1155/2023/6688623
work_keys_str_mv AT echaters improvementoftardivedyskinesiaswitholanzapine
AT oneibb improvementoftardivedyskinesiaswitholanzapine